Ëva Katona

2.3k total citations
75 papers, 1.7k citations indexed

About

Ëva Katona is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Physiology. According to data from OpenAlex, Ëva Katona has authored 75 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 34 papers in Hematology and 15 papers in Physiology. Recurrent topics in Ëva Katona's work include Blood properties and coagulation (42 papers), Platelet Disorders and Treatments (18 papers) and Erythrocyte Function and Pathophysiology (13 papers). Ëva Katona is often cited by papers focused on Blood properties and coagulation (42 papers), Platelet Disorders and Treatments (18 papers) and Erythrocyte Function and Pathophysiology (13 papers). Ëva Katona collaborates with scholars based in Hungary, United States and Netherlands. Ëva Katona's co-authors include László Muszbek, Zsuzsanna Bereczky, Zsuzsa Bagoly, István Komáromi, Levente Kárpáti, Gizella Haramura, Dénes Páll, István Balogh, Éva Ajzner and Róza Ádány and has published in prestigious journals such as Physiological Reviews, Blood and Scientific Reports.

In The Last Decade

Ëva Katona

72 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ëva Katona Hungary 20 1.1k 913 278 212 143 75 1.7k
Kristina F. Standeven United Kingdom 20 841 0.8× 492 0.5× 180 0.6× 250 1.2× 220 1.5× 26 1.5k
Angela M. Carter United Kingdom 20 489 0.4× 412 0.5× 169 0.6× 167 0.8× 283 2.0× 36 1.7k
Sofia Ramström Sweden 21 256 0.2× 654 0.7× 59 0.2× 316 1.5× 48 0.3× 67 1.2k
Petra Stohlawetz Austria 22 167 0.1× 748 0.8× 101 0.4× 465 2.2× 329 2.3× 37 1.7k
Shirley P. Levine United States 21 309 0.3× 600 0.7× 77 0.3× 375 1.8× 56 0.4× 28 1.4k
Christoph Bidlingmaier Germany 21 143 0.1× 1.1k 1.2× 144 0.5× 158 0.7× 134 0.9× 64 2.0k
P Vague France 20 492 0.4× 364 0.4× 203 0.7× 322 1.5× 468 3.3× 71 2.0k
J L Wautier France 13 364 0.3× 320 0.4× 321 1.2× 105 0.5× 64 0.4× 40 1.1k
F. I. Pareti Italy 18 277 0.2× 1.2k 1.4× 63 0.2× 337 1.6× 123 0.9× 38 1.9k
Sandrine Laradi France 19 97 0.1× 495 0.5× 290 1.0× 63 0.3× 183 1.3× 77 1.3k

Countries citing papers authored by Ëva Katona

Since Specialization
Citations

This map shows the geographic impact of Ëva Katona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ëva Katona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ëva Katona more than expected).

Fields of papers citing papers by Ëva Katona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ëva Katona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ëva Katona. The network helps show where Ëva Katona may publish in the future.

Co-authorship network of co-authors of Ëva Katona

This figure shows the co-authorship network connecting the top 25 collaborators of Ëva Katona. A scholar is included among the top collaborators of Ëva Katona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ëva Katona. Ëva Katona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gindele, Réka, et al.. (2024). Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations. International Journal of Molecular Sciences. 25(5). 2893–2893.
2.
Sang, Yaqiu, Robert H. Lee, Ëva Katona, et al.. (2024). Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation. Blood Advances. 8(19). 5072–5085. 2 indexed citations
3.
Harangi, Mariann, et al.. (2023). A dipeptidil-peptidáz-4-gátlók szerepe a 2-es típusú diabetes mellitus kezelésében napjainkban. Repository of the Academy's Library (Library of the Hungarian Academy of Sciences). 31(2). 113–122. 1 indexed citations
4.
Horváth, Emőke, Helga Bárdos, Ëva Katona, et al.. (2023). Cellular FXIII in Human Macrophage-Derived Foam Cells. International Journal of Molecular Sciences. 24(5). 4802–4802. 1 indexed citations
5.
Katona, Ëva, et al.. (2022). The Effect of Activated FXIII, a Transglutaminase, on Vascular Smooth Muscle Cells. International Journal of Molecular Sciences. 23(10). 5845–5845. 2 indexed citations
6.
Szegedi, István, Ëva Katona, István Fekete, et al.. (2022). Low α2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis. Frontiers in Cardiovascular Medicine. 9. 901286–901286. 3 indexed citations
7.
8.
9.
10.
Kovács, Zsuzsanna, Ëva Katona, Gizella Haramura, et al.. (2020). N‐glycosylation of blood coagulation factor XIII subunit B and its functional consequence. Journal of Thrombosis and Haemostasis. 18(6). 1302–1309. 8 indexed citations
11.
Bagoly, Zsuzsa, et al.. (2019). A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids. Journal of Immunological Methods. 471. 27–33. 7 indexed citations
12.
Bryk, Agata Hanna, Jakub Siudut, Elżbieta Broniatowska, et al.. (2019). Sex-specific alteration to α2-antiplasmin incorporation in patients with type 2 diabetes. Thrombosis Research. 185. 55–62. 9 indexed citations
13.
Muszbek, László, et al.. (2017). Assessment of Factor XIII. Methods in molecular biology. 1646. 277–293. 12 indexed citations
14.
Katona, Ëva, et al.. (2016). Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome – characterization of the antibody. Journal of Thrombosis and Haemostasis. 14(8). 1517–1520. 6 indexed citations
15.
16.
Orosz, Zsuzsanna, Ëva Katona, Andrea Facskó, András Berta, & László Muszbek. (2010). A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears. Journal of Immunological Methods. 353(1-2). 87–92. 7 indexed citations
17.
Orosz, Zsuzsanna, Ëva Katona, Andrea Facskó, et al.. (2010). Factor XIII subunits in human tears; their highly elevated levels following penetrating keratoplasty. Clinica Chimica Acta. 412(3-4). 271–276. 10 indexed citations
18.
Muszbek, László, Zsuzsa Bagoly, Zsuzsanna Bereczky, & Ëva Katona. (2008). The Involvement of Blood Coagulation Factor XIII in Fibrinolysis and Thrombosis. Cardiovascular & Hematological Agents in Medicinal Chemistry. 6(3). 190–205. 109 indexed citations
19.
Audikovszky, Mária, I. Serés, Mariann Harangi, et al.. (2006). Orlistat increases serum paraoxonase activity in obese patients. Nutrition Metabolism and Cardiovascular Diseases. 17(4). 268–273. 31 indexed citations
20.
Páll, Dénes, et al.. (2000). Prevalence of cardiovascular risk factors of the smokers and non-smokers in the city of Debrecen, Hungary. Public Health. 114(4). 295–299. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristina F. Standeven Breakdown of academic impact, for papers by Angela M. Carter Breakdown of academic impact, for papers by Sofia Ramström Breakdown of academic impact, for papers by Petra Stohlawetz Breakdown of academic impact, for papers by Shirley P. Levine Breakdown of academic impact, for papers by Christoph Bidlingmaier Breakdown of academic impact, for papers by P Vague Breakdown of academic impact, for papers by J L Wautier Breakdown of academic impact, for papers by F. I. Pareti Breakdown of academic impact, for papers by Sandrine Laradi
Rankless by CCL
2026